<code id='8F2ED0603E'></code><style id='8F2ED0603E'></style>
    • <acronym id='8F2ED0603E'></acronym>
      <center id='8F2ED0603E'><center id='8F2ED0603E'><tfoot id='8F2ED0603E'></tfoot></center><abbr id='8F2ED0603E'><dir id='8F2ED0603E'><tfoot id='8F2ED0603E'></tfoot><noframes id='8F2ED0603E'>

    • <optgroup id='8F2ED0603E'><strike id='8F2ED0603E'><sup id='8F2ED0603E'></sup></strike><code id='8F2ED0603E'></code></optgroup>
        1. <b id='8F2ED0603E'><label id='8F2ED0603E'><select id='8F2ED0603E'><dt id='8F2ED0603E'><span id='8F2ED0603E'></span></dt></select></label></b><u id='8F2ED0603E'></u>
          <i id='8F2ED0603E'><strike id='8F2ED0603E'><tt id='8F2ED0603E'><pre id='8F2ED0603E'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:613
          Attendees at the MedTech Conference in Anaheim, California. -- health tech coverage from STAT
          Attendees at the AdvaMed Conference in Anaheim, Calif., on Tuesday. Eric Thayer for STAT

          ANAHEIM, Calif. — Thousands of workers in the medical device industry gathered here this week for the MedTech Conference, creating an eerie dissonance with Disneyland tourists clad in Mickey Mouse ears and fanny packs.

          Device makers and analysts at the conference, hosted by device lobby AdvaMed, came together to discuss medical technology’s innovation problem, the industry’s deepening relationship with the Food and Drug Administration, and the growing opportunities in digital health.

          advertisement

          After a couple of years of tremendous gains generated by the pandemic’s demand for medical equipment, the medical device industry has hit a slump. In its annual medtech report, EY reported a 30% decline in all industry financing, which includes a drop in initial public offerings, special-purpose acquisition company deals, and venture capital funding.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          The lessons of Aduhelm, an Alzheimer's drug that was not to be
          The lessons of Aduhelm, an Alzheimer's drug that was not to be

          StevenSenn/APAduhelm,apioneeringtreatmentforAlzheimer’sdiseasethatcollapsedundercorporatemistakesand

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          It was time to plan for my old age. If only I could stop crying

          MikeReddyforSTATAtwo-dayexcursiontoNewHampshire,atthepeakoffallfoliageseason,shouldbeatreat.Sohowcom